Literature DB >> 2103491

Biological and clinical significance of cathepsin D in breast cancer.

H Rochefort1.   

Abstract

Cathepsin D is an acidic lysosomal protease present in all cells. In breast cancer cells, pro-cathepsin D expression and secretion are markedly increased and its processing is altered. This protease is induced by estrogens and growth factors. In vitro, pro-cathepsin D is an autocrine mitogen on breast cancer cells and can be auto-activated to degrade extracellular matrix and proteoglycans in acidic microenvironment. In patients, there is a significant correlation between high cathepsin D concentrations in the cytosol of primary breast cancer and development of metastasis. This marker is independent of other prognostic factors and appears to be particularly useful in lymph node-negative tumors. These results suggest that derouting and overexpression of cathepsin D plays an important role in invasion and metastasis of breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2103491

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  15 in total

Review 1.  Active cell death in hormone-dependent tissues.

Authors:  M P Tenniswood; R S Guenette; J Lakins; M Mooibroek; P Wong; J E Welsh
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

2.  Malignant transformation alters intracellular trafficking of lysosomal cathepsin D in human breast epithelial cells.

Authors:  Y Nishimura; M Sameni; B F Sloane
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

3.  Modulation of cathepsin D activity in retinal pigment epithelial cells.

Authors:  P E Rakoczy; C M Lai; M Baines; S Di Grandi; J H Fitton; I J Constable
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

4.  Crystal structure of human pepsin and its complex with pepstatin.

Authors:  M Fujinaga; M M Chernaia; N I Tarasova; S C Mosimann; M N James
Journal:  Protein Sci       Date:  1995-05       Impact factor: 6.725

5.  Estrogen modulates hepatic gene expression and survival of rainbow trout infected with pathogenic bacteria Yersinia ruckeri.

Authors:  Michael Wenger; Aleksei Krasnov; Stanko Skugor; Elinor Goldschmidt-Clermont; Ursula Sattler; Sergey Afanasyev; Helmut Segner
Journal:  Mar Biotechnol (NY)       Date:  2012-07-24       Impact factor: 3.619

6.  Bicarbonate increases tumor pH and inhibits spontaneous metastases.

Authors:  Ian F Robey; Brenda K Baggett; Nathaniel D Kirkpatrick; Denise J Roe; Julie Dosescu; Bonnie F Sloane; Arig Ibrahim Hashim; David L Morse; Natarajan Raghunand; Robert A Gatenby; Robert J Gillies
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

7.  Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design.

Authors:  E T Baldwin; T N Bhat; S Gulnik; M V Hosur; R C Sowder; R E Cachau; J Collins; A M Silva; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples.

Authors:  M R Emmert-Buck; M J Roth; Z Zhuang; E Campo; J Rozhin; B F Sloane; L A Liotta; W G Stetler-Stevenson
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

9.  Expression and immunohistochemical localization of cathepsin L during the progression of human gliomas.

Authors:  M Sivaparvathi; M Yamamoto; G L Nicolson; Z L Gokaslan; G N Fuller; L A Liotta; R Sawaya; J S Rao
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

10.  Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival.

Authors:  E Campo; J Muñoz; R Miquel; A Palacín; A Cardesa; B F Sloane; M R Emmert-Buck
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.